or
forgot password
  • cancer clinical trials in maywood, IL

  • S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Breast Cancer
    S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Ovarian Cancer, Peritoneal Cavity Cancer
    Genetic Study of Young Patients With Colorectal Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Colorectal Cancer
    S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Lung Cancer
    Imatinib Mesylate in Treating Patients With Salivary Gland Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Head and Neck Cancer
    Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Carcinoma of Unknown Primary
    S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Leukemia
    S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Colorectal Cancer
    S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Lymphoma, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Leukemia
    Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific
    Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine
    Loyola University Medical Center
    Maywood, Illinois 60153
    Pancreatic Cancer
    Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Head and Neck Cancer
    S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Bladder Cancer, Urethral Cancer
    CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
    Loyola University Medical Center
    Maywood, Illinois 60153
    Multiple Myeloma
    T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients
    Loyola University of Chicago
    Maywood, Illinois 60153
    Hepatocellular Carcinoma
    Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Lung Cancer
    S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer
    Loyola University Medical Center
    Maywood, Illinois 60153
    Cervical Cancer
    Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Head and Neck Cancer
    SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism
    Loyola University Medical Center and Outpatient Clinic
    Maywood, Illinois 60153
    Pulmonary Embolism
    Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Cervical Cancer
    Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter
    S0222: Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Lung Cancer
    Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Lung Cancer
    S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Sarcoma
    Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Cervical Cancer
    SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis
    Loyola University Medical Center

    Trial Locations
    Loyola University Medical Center
    Cardinal Bernardin Cancer Center
    Pulmonary Embolism, Deep Vein Thrombosis
    FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Ovarian Cancer
    S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Esophageal Cancer
    Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers
    Loyola University Medical Center
    Maywood, Illinois 60153
    Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome, Non-Hodgkin Lymphoma, Chronic Myelogenous Leukemia
    S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Lung Cancer, Pulmonary Complications
    Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Sarcoma
    MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
    Cardinal Bernardin Cancer Center, Loyola Unv. Med. Ctr.
    Maywood, Illinois 60153
    Melanoma, Metastases
    A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)
    Loyola Univ. Medical Center
    Maywood, Illinois 60153
    Non-Small-Cell Lung Carcinoma, Neoplasm Recurrence, Local
    S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Head and Neck Cancer
    Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients
    Loyola University Medical Center
    Maywood, Illinois 60153
    Lymphoma, Non-Hodgkin
    Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients
    Loyola University Medical Center
    Maywood, Illinois 60153
    Multiple Myeloma
    S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Melanoma (Skin)
    Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women
    Loyola University Medical Center
    Maywood, Illinois 60153
    Breast Neoplasm
    S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Breast Cancer
    S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Sarcoma
    Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Lung Cancer
    S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Lymphoma
    Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
    Loyola University Medical Center
    Maywood, Illinois 60153
    Leukemia, Myeloid, Acute
    Maribavir for Prevention of CMV After Stem Cell Transplants
    Loyola University
    Maywood, Illinois 60153
    Cytomegalovirus Infection
    Safety and Tolerability of Repeat Courses of IM Alefacept
    Loyola University Medical Center
    Maywood, Illinois 60153
    Chronic Plaque Psoriasis
    S0509: AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Malignant Mesothelioma
    Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Lung Cancer
    Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)
    Loyola University Medical Center

    Trial Locations
    Loyola University Medical Center
    Loyola University Chicago-Cardinal Bernardin Cancer Center
    Myelodysplastic Syndrome (MDS)
    CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
    Loyola University Medical Center
    Maywood, Illinois 60153
    B-cell Chronic Lymphocytic Leukemia, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Malignant Neoplasm, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Splenic Marginal Zone Lymphoma, Waldenström Macroglobulinemia
    Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the Brain
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Kidney Cancer, Metastatic Cancer
    Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia
    Loyola University Medical Center
    Maywood, Illinois 60153
    Chronic Myeloid Leukemia
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Loyola University Medical Center
    Maywood, Illinois 60153
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
    Loyola University Medical Center
    Maywood, Illinois 60153
    Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Brain and Central Nervous System Tumors
    Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients
    Loyola University Medical Center
    Maywood, Illinois 60153
    Lymphoma, Non-Hodgkin, Multiple Myeloma
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    Loyola University Medical Center
    Maywood, Illinois 60153
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Loyola University Medical Center
    Maywood, Illinois 60153
    Atrial Fibrillation, Atrial Flutter
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Cardinal Bernardin Cancer Center at Loyola University Medical Center
    Maywood, Illinois 60153-5500
    Leukemia
    Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia
    Loyola University Medical Center
    Maywood, Illinois 60153
    Acute Lymphoblastic Leukemia (ALL)
    Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Patients
    Loyola University Medical Center /Cardinal Bernardin Cancer Loyola Univ Med Ctr
    Maywood, Illinois 60153
    Multiple Myeloma